Hangzhou AGS MedTech Co. Ltd. A (688581.SS) stock: key figures, P/E, revenue and dividend

Health Care · Health Care Equipment · China · ISIN CNE100005ZF0

Price
50.38 CNY
Market cap
4.09 bn CNY
P/E (2025)
18.43
P/S (2025)
6.88
Dividend yield
2.06 %
Net margin
37.34 %
Return on equity (ROE)
8.81 %
Return on assets (ROA)
8.28 %

Hangzhou AGS MedTech Co. Ltd. A financials

Fiscal year20242025
Revenue636.63 m CNY593.74 m CNY
Gross profit459.08 m CNY422.07 m CNY
Operating income288.24 m CNY223.81 m CNY
EBIT343.65 m CNY262.15 m CNY
Net income293.39 m CNY221.71 m CNY
Diluted EPS – continuing operations3.62 CNY2.73 CNY

Full history since 2021, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Hangzhou AGS MedTech Co. Ltd. A

Hangzhou AGS MedTech Co., Ltd., together with its subsidiaries, engages in the research, development, production, sale, and service of endoscopic minimally invasive diagnostic and therapeutic devices in China and internationally. The company offers hemostasis products, including hemoclips and traction clips; biopsy products, such as disposable biopsy, swinging biopsy, and grasping forceps; and EMR products comprising polypectomy snares and disposable sclerotherapy needles. It also provides ESD products, which include electrosurgical generators, endoscopic C02 regulation units, endoscopic water pumps, single use electrosurgical knife combination, and bipolar coagulation forceps; ERCP products, such as disposable guide wires, disposable stone extraction baskets, stone retrieval balloons, and sphincterotome; and accessories, including disposable endoscope cleaning brushes. The company was incorporated in 2010 and is headquartered in Hangzhou, China.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.